Merck's HIV protease map project
Executive Summary
Firm making the rounds among Capitol Hill members involved in health and biotech issues to describe its AIDS inhibitor development program and answer questions on mapping project that received publicity earlier this winter. Merck Sharp & Dohme Research Labs President Edward Scolnick made visits during the week ended April 7.